Ethical assessment of pediatric research protocols
Related Experiment Video
Updated: Jul 10, 2026
A Familiarization Protocol Facilitates the Participation of Children with ASD in Electrophysiological Research
Published on: July 31, 2017
1Department of Social Medicine, Harvard Medical School, 651 Huntington Avenue, 02115, Boston, MA, USA. robert.truog@childrens.harvard.edu
Insights
Protecting critically ill children in research requires careful risk assessment. Component analysis helps separate medical care risks from research risks, ensuring ethical pediatric studies.
Area of Science:
- Pediatric Research Ethics
- Clinical Trial Oversight
- Bioethics
Background:
- International regulations for pediatric research prioritize subject protection over informed consent, unlike adult research.
- Critically ill children face inherent high risks, complicating ethical justification for research participation.
- Existing frameworks for research oversight in children vary globally but share core ethical principles.
Purpose of the Study:
- To introduce a structured approach for evaluating the ethical permissibility of research involving critically ill children.
- To differentiate risks associated with standard medical care from those introduced by research interventions.
- To provide a framework for assessing the net risks and scientific justification of pediatric clinical trials.
Main Methods:
- Utilizing 'component analysis' to dissect research protocols into individual interventions.
- Applying a three-step ethical evaluation process for research components.
- Assessing interventions based on risk-benefit ratios and adherence to pediatric research risk thresholds.
Main Results:
- Component analysis effectively distinguishes between risks from medical care and research.
- Ethically justifiable interventions include those with benefits meeting or exceeding risks.
- Interventions with risks exceeding benefits require justification based on minimal risk thresholds and significant scientific value.
Conclusions:
- A systematic component analysis and three-step ethical review are crucial for responsible pediatric research.
- This approach ensures that research involving critically ill children minimizes risk while maximizing scientific benefit for future patients.
- Adherence to defined risk thresholds and demonstration of substantial scientific merit are essential for ethical approval.
Abstract:
Specific regulations regarding oversight of research in children vary from country to country, but most share common principles derived from major consensus documents. Whereas the permissibility of research on adults depends heavily upon the informed consent of the subject, the regulation of research in pediatrics is focused primarily upon protection of the subjects from research risks. Since patients who require intensive care are commonly at high risk for complications related to the severity of their illnesses, justifying the risks of research on critically ill children may therefore be particularly challenging. Use of an approach known as "component analysis" can be very helpful in separating the risks attributable to the medical care itself from those that should be ascribed to the research. After identifying and isolating the research interventions, a three-step approach is helpful for evaluating the "net risks" of the research: (1) Separate each component of the research into discrete interventions. (2) Any intervention for which the benefits equal or exceed the risks is ethically justified. (3) For interventions in which the risks exceed the benefits, the "net risk" for each intervention needs to be justified, as follows: (a) the interventions may not exceed the locally defined threshold for pediatric research (e.g., not greater than a minor increment more than minimal risk, as in the U.S. regulations); and (b) the scientific value of the study for improving the care of future children must be sufficient to justify the sum of the net risks of the research interventions.
Related Concept Videos
01:56Ethics in Research
01:17Ethical Dilemmas I
Let us explore some examples to understand the potentially complex moral decisions nurses face.
Take the case of caring for minors, particularly in areas related to reproductive...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism